Stay updated on RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.

Latest updates to the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedFooter revision history updated to include Revision: v3.5.2 and remove Revision: v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded the term 'Small cell lung carcinoma' to the listed conditions and included a 'Genetic and Rare Diseases Information Center' resource entry.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated to v3.4.2; the previous government funding notices and the v3.4.1 revision text were removed. No study data or eligibility information appears affected.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status, and updated the site version to v3.4.1 with removal of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to RadioSurgery and Nivolumab for Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.